NAGE earnings: real EPS beat/miss history, analyst consensus Buy, P/E 14.49. Updated 2026-07-23.
Niagen Bioscience (NAGE) Research Hub
Niagen Bioscience (NAGE) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.04 USD (-0.33%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 14.49, market cap 0.27B. This hub links to the full technical, earnings and options research available for NAGE.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.04 USD (-0.33%) |
| 52-week range | 2.92 USD – 3.64 USD |
| Trend regime | Range |
| 14-day RSI | 44.4 (Bearish) |
| Trailing P/E | 14.49 |
| Market cap | 0.27B |
| Dividend yield | 0.00% |
Available research for NAGE
Covered Call on NAGE: how it works, illustrative setup around the real 3.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NAGE: how it works, illustrative setup around the real 3.04 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NAGE: how it works, illustrative setup around the real 3.04 USD price, max profit/loss, breakeven and when to use it. Educational.
NAGE technical analysis: range, last 3.04 USD, RSI 44.4, 52w range 2.92 USD–3.64 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is NAGE in?
Niagen Bioscience (NAGE) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NAGE in an uptrend or downtrend?
As of 2026-09-11, NAGE is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NAGE's trailing P/E ratio?
NAGE's trailing P/E is 14.49, with a market cap of 0.27B. See the earnings research page for full valuation detail.